Tissue-engineered vascular grafts: autologous off-the-shelf vascular access?

Published

Journal Article (Review)

Dialysis grafts have provided reliable access for millions of patients in need of renal replacement therapy. However, regardless of the material used for artificial dialysis grafts their mean patency remains generally poor and infection rates are greater than native arteriovenous fistulas. The need for superior alternatives to conventional synthetic materials used for vascular access has been an area of investigation for more than 25 years and recently there has been a great deal of progress in the field of tissue-engineered vascular grafts. Many of these technologies are either commercially available or are now entering early phases of clinical trials. This review briefly covers the history, potential advantages, and disadvantages of these technologies, which are likely to create an impact in the field of vascular access surgery.

Full Text

Duke Authors

Cited Authors

  • Manson, RJ; Unger, JM; Ali, A; Gage, SM; Lawson, JH

Published Date

  • November 2012

Published In

Volume / Issue

  • 32 / 6

Start / End Page

  • 582 - 591

PubMed ID

  • 23217339

Pubmed Central ID

  • 23217339

Electronic International Standard Serial Number (EISSN)

  • 1558-4488

Digital Object Identifier (DOI)

  • 10.1016/j.semnephrol.2012.10.010

Language

  • eng

Conference Location

  • United States